Loading...
Macleods Pharmaceuticals Ltd — Hydrochlorothiazide Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #2 for Hydrochlorothiazide · $25.4M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #2 Indian exporter of Hydrochlorothiazide with $25.4M in export value and 509 verified shipments. Macleods Pharmaceuticals Ltd holds a 7.3% market share in Hydrochlorothiazide exports across 29 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $9.1M | 392 | 69.1% |
| GREECE | $821.5K | 27 | 6.2% |
| HONDURAS | $467.4K | 28 | 3.5% |
| POLAND | $325.6K | 39 | 2.5% |
| GERMANY | $325.0K | 9 | 2.5% |
| CHILE | $298.0K | 14 | 2.3% |
| MALTA | $283.3K | 9 | 2.1% |
| SOUTH AFRICA | $228.4K | 16 | 1.7% |
| FRANCE | $162.1K | 15 | 1.2% |
| CROATIA | $147.1K | 9 | 1.1% |
Macleods Pharmaceuticals Ltd exports Hydrochlorothiazide to 35 countries. The largest destination is UNITED STATES accounting for 69.1% of Macleods Pharmaceuticals Ltd's Hydrochlorothiazide shipments, followed by GREECE (6.2%) and HONDURAS (3.5%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MACLEODS PHARMA USA INC | UNITED STATES | $3.3M | 151 |
| MACLEODS PHARMA USA,INC | UNITED STATES | $2.3M | 79 |
| MACLEODS PHARMA USA ,INC | UNITED STATES | $1.5M | 85 |
| MACLEODS PHARMA USA,INC, | UNITED STATES | $760.6K | 28 |
| DEMO SA PHARMACEUTICAL INDUSTRY | GREECE | $618.8K |
India exported $119.2M worth of Hydrochlorothiazide through 6,947 shipments from 403 suppliers to 149 countries, serving 1,130 buyers globally. Macleods Pharmaceuticals Ltd contributes $25.4M to this total, accounting for 7.3% of India's Hydrochlorothiazide exports. Macleods Pharmaceuticals Ltd ships Hydrochlorothiazide to 35 countries through 77 buyers.
Macleods Pharmaceuticals Ltd's average Hydrochlorothiazide shipment value is $50.0K per consignment, based on 509 shipments totaling $25.4M. The largest destination is UNITED STATES (69.1% of Macleods Pharmaceuticals Ltd's Hydrochlorothiazide exports).
Macleods Pharmaceuticals Ltd ranks #2 among 403 Indian Hydrochlorothiazide exporters with a 7.3% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($25.4M), UNICHEM LABORATORIES LIMITED ($21.3M), MYLAN LABORATORIES LIMITED ($16.4M). Macleods Pharmaceuticals Ltd processed 509 shipments to 29 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IRBESARTAN 150MG AND HYDROCHLOROTHIAZIDE | $400.0K | 15 |
| IRBESARTAN 300MG AND HYDROCHLOROTHIAZIDE | $252.5K | 8 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (320 MG/ 25 MG) | $204.1K | 10 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS USP (32 mg | $200.0K | 4 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (160 mg/ 12.5 mg) | $178.1K | 5 |
| AMLODIPINE AND VALSARTAN HYDROCHLOROTHIAZIDE TABLETS 5/160MG(COVADIR 5 /160MG)(3X 10S TABS) | $175.7K | 9 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES IRBESARTAN AND HYDROCHLOROTHIAZIDETABLETS USP 300 mg/12.5 mg | $172.0K | 8 |
| IRBESARTAN 300MG HYDROCHLOROTHIAZIDE 25M |
What Macleods Pharmaceuticals Ltd must comply with to export Hydrochlorothiazide to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MACLEODS PHARMACEUTICALS LTD ★ | $25.4M | 509 | 29 | $50.0K |
| 1 | UNICHEM LABORATORIES LIMITED | $21.3M | 425 | 2 | $50.0K |
| 3 | MYLAN LABORATORIES LIMITED | $16.4M | 329 | 7 | $50.0K |
Macleods Pharmaceuticals Ltd ranks #2 among 403 Indian Hydrochlorothiazide exporters. Average shipment value of $50.0K compared to the market average of $295.9K.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,041 | 15.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 621 | 8.9% |
| NHAVA SHEVA SEA (INNSA1) | 621 | 8.9% |
| JNPT/ NHAVA SHEVA SEA | 493 | 7.1% |
| DELHI AIR | 319 | 4.6% |
| JNPT | 312 | 4.5% |
| Bombay Air | 252 | 3.6% |
| HYDERABAD ICD | 210 | 3.0% |
Visual overview of India's hydrochlorothiazide supplier profile for Macleods Pharmaceuticals Ltd — top suppliers, destinations, pricing, and trade routes
Latest developments and market context
Detailed market intelligence for Hydrochlorothiazide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Hydrochlorothiazide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| 22 |
| MACLEODS PHARMA USA,INC.. | UNITED STATES | $493.1K | 12 |
| HEUMANN PHARMA GMBH & CO. | MALTA | $483.2K | 14 |
| MACLEODS PHARMA USA, INC.,. | UNITED STATES | $322.3K | 8 |
| DROGUERIA AVICENNA S,A DE C,V | HONDURAS | $258.3K | 11 |
| DEMO SA | GREECE | $202.7K | 5 |
Macleods Pharmaceuticals Ltd supplies Hydrochlorothiazide to 77 buyers globally. The largest buyer is MACLEODS PHARMA USA INC (UNITED STATES), followed by MACLEODS PHARMA USA,INC (UNITED STATES) and MACLEODS PHARMA USA ,INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $171.4K |
| 4 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (320 mg/ 25 mg) | $150.0K | 3 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (320 mg/ 12.5 mg) | $144.4K | 4 |
Macleods Pharmaceuticals Ltd exports 457 distinct Hydrochlorothiazide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRBESARTAN 150MG AND HYDROCHLOROTHIAZIDE with 15 shipments worth $400.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 149+ countries, 1,130+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Hydrochlorothiazide. For current shipment-level data, contact TransData Nexus.